{
      "brief_title": [
            "erlotinib",
            "standard",
            "chemotherapy",
            "patient",
            "advance",
            "cell",
            "lung",
            "cancer",
            "nsclc",
            "eastern",
            "cooperative",
            "oncology",
            "group",
            "ecog",
            "performance",
            "status",
            "p",
            "2"
      ],
      "brief_summary": [
            "purpose",
            "noncomparative",
            "study",
            "obtain",
            "preliminary",
            "estimate",
            "efficacy",
            "erlotinib",
            "standard",
            "chemotherapy",
            "patient",
            "advance",
            "previously",
            "untreated",
            "nonsmall",
            "cell",
            "lung",
            "cancer",
            "nsclc",
            "eastern",
            "cooperative",
            "oncology",
            "group",
            "ecog",
            "performance",
            "status",
            "p",
            "2",
            "study",
            "also",
            "evaluate",
            "safety",
            "erlotinib",
            "patient",
            "population"
      ],
      "condition": [
            "cell",
            "lung",
            "cancer"
      ],
      "intervention_type": [
            "Drug",
            "Drug"
      ],
      "intervention_name": [
            "Tarceva (Trademark) (erlotinib HCl, OSI-774)",
            "Combination carboplatin and paclitaxel"
      ],
      "description": [
            "tablet",
            "administer",
            "orally",
            "150",
            "start",
            "dose",
            "100",
            "reduce",
            "dose",
            "continuous",
            "therapy",
            "200",
            "iv",
            "infusion",
            "3",
            "hour",
            "carboplatin",
            "auc",
            "6",
            "x",
            "min",
            "iv",
            "15",
            "30",
            "minute",
            "give",
            "day",
            "1",
            "every",
            "21",
            "day",
            "4",
            "cycle"
      ],
      "arm_group_label": [
            "chemotherapy"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "stage",
            "iiib",
            "iv",
            "nonsmall",
            "cell",
            "lung",
            "cancer",
            "nsclc",
            "prior",
            "chemotherapy",
            "eastern",
            "cooperative",
            "oncology",
            "group",
            "ecog",
            "performance",
            "status",
            "2",
            "clinically",
            "radiologically",
            "measurable",
            "disease",
            "per",
            "recist",
            "criterion",
            "exclusion",
            "criterion",
            "abnormality",
            "concurrent",
            "anticancer",
            "therapy",
            "prior",
            "treatment",
            "epidermal",
            "growth",
            "factor",
            "receptor",
            "egfr",
            "inhibitor",
            "kind",
            "active",
            "malignancy",
            "uncontrolled",
            "brain",
            "metastasis",
            "severe",
            "abnormality",
            "cornea",
            "significant",
            "cardiac",
            "disease"
      ],
      "gender": "All",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "keyword": [],
      "mesh_term": [
            "neoplasm",
            "lung",
            "paclitaxel",
            "hydrochloride"
      ],
      "id": "NCT00085839"
}